Transspinal Stimulation + Locomotor Training for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
Locomotor training is often used with the aim to improve corticospinal function and walking ability in individuals with Spinal Cord Injury. Excitingly, the benefits of locomotor training may be augmented by noninvasive electrical stimulation of the spinal cord and enhance motor recovery at SCI. This study will compare the effects of priming locomotor training with high-frequency noninvasive thoracolumbar spinal stimulation. In people with motor-incomplete SCI, a series of clinical and electrical tests of brain and spinal cord function will be performed before and after 40 sessions of locomotor training where spinal stimulation is delivered immediately before either lying down or during standing.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes people taking medications that may change the seizure threshold. It's best to discuss your specific medications with the trial team.
What data supports the effectiveness of the treatment Transspinal Stimulation + Locomotor Training for Spinal Cord Injury?
Research shows that robotic-assisted gait training (RAGT) can significantly improve walking ability, leg strength, and mobility in people with spinal cord injuries, especially when started early. Additionally, combining robotic-assisted rehabilitation with non-invasive brain stimulation can further enhance motor function in the lower body.12345
Is robotic-assisted gait training safe for people with spinal cord injury?
How does the treatment Transspinal Stimulation + Locomotor Training for Spinal Cord Injury differ from other treatments?
This treatment is unique because it combines robotic gait training with transcutaneous spinal stimulation, which aims to enhance neuroplasticity (the brain's ability to reorganize itself) and improve walking function by reactivating dormant neural pathways in the spinal cord. Unlike traditional therapies, it uses electrical stimulation to modulate spinal networks, potentially leading to better recovery of movement and coordination.89101112
Research Team
Noam Y Harel, MD PhD
Principal Investigator
Bronx Veterans Medical Research Foundation
Maria Knikou, PT, PhD
Principal Investigator
Research Foundation of the City University of New York
Eligibility Criteria
This trial is for adults aged 18-70 with motor-incomplete spinal cord injury (SCI) above the T10 level, who can sign consent and commit to the study duration. They must be in good health, have a bone mineral density T-score <3.5 SD from norms, reflexes present for soleus H-reflex testing, flexible ankle joints without contractures, first-time SCI due to trauma or similar causes, and at least 6 months post-SCI.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Robotic Gait Training (Behavioural Intervention)
- Transspinal Stimulation (Electrical Stimulation)
Robotic Gait Training is already approved in Canada, Switzerland for the following indications:
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
City University of New York
Lead Sponsor
Bronx Veterans Medical Research Foundation, Inc
Collaborator
Icahn School of Medicine at Mount Sinai
Collaborator